Table 1.

Demographic Characteristics of the Study Population

Characteristic	Number of Patients (Total 94)
Age (years)
Mean (±SD)	67.25 (10.25)
Gender
Males	63 (67.7%)
Females	31 (32.3%)
Treatment Status
Treatment-naive	20 (21.3%)
Previously treated	74 (78.7%)
Total number of prior injections in switch therapy group
Mean (±SD)	8.63 (4.74)
Total number of IVI brolucizumab per patient
Mean (±SD)	1.36 (± 0.58)
Interval between IVI brolucizumab in weeks
Mean (±SD)	10.2 ± 2.1

Abbreviations: SD, standard deviation; IVI, intravitreal injection.